Comerica Bank Eagle Pharmaceuticals, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.63 - $15.21 $625 - $2,053	-135 Reduced 21.57%	491 $2,000
Q3 2023 Nov 21, 2023	BUY	$15.21 - $22.88 $9,521 - $14,322	626 New	626 $9,000
Q4 2022 Jan 26, 2023	SELL	$24.98 - $39.77 $48,711 - $77,551	-1,950 Reduced 23.51%	6,345 $0
Q3 2022 Oct 28, 2022	SELL	$26.42 - $47.12 $34,610 - $61,727	-1,310 Reduced 13.64%	8,295 $257,000
Q2 2022 Aug 02, 2022	SELL	$41.26 - $51.35 $15,472 - $19,256	-375 Reduced 3.76%	9,605 $418,000
Q1 2022 Apr 27, 2022	BUY	$44.58 - $52.6 $48,146 - $56,808	1,080 Added 12.13%	9,980 $493,000
Q4 2021 Feb 18, 2022	SELL	$45.82 - $56.9 $48,111 - $59,745	-1,050 Reduced 10.55%	8,900 $453,000
Q3 2021 Nov 22, 2021	SELL	$43.79 - $55.78 $18,348 - $23,371	-419 Reduced 4.04%	9,950 $555,000
Q2 2021 Aug 26, 2021	SELL	$36.86 - $44.5 $28,971 - $34,977	-786 Reduced 7.05%	10,369 $443,000
Q1 2021 Apr 28, 2021	SELL	$40.32 - $50.97 $22,780 - $28,798	-565 Reduced 4.82%	11,155 $465,000
Q4 2020 Jan 28, 2021	SELL	$41.72 - $51.34 $20,067 - $24,694	-481 Reduced 3.94%	11,720 $545,000
Q3 2020 Oct 30, 2020	BUY	$37.02 - $51.28 $68,375 - $94,714	1,847 Added 17.84%	12,201 $518,000
Q2 2020 Jul 31, 2020	BUY	$43.24 - $55.02 $25,208 - $32,076	583 Added 5.97%	10,354 $496,000
Q1 2020 May 01, 2020	BUY	$34.37 - $60.07 $10,276 - $17,960	299 Added 3.16%	9,771 $449,000
Q4 2019 Feb 07, 2020	BUY	$54.32 - $64.31 $1,303 - $1,543	24 Added 0.25%	9,472 $569,000
Q3 2019 Oct 31, 2019	SELL	$53.25 - $59.98 $5,325 - $5,998	-100 Reduced 1.05%	9,448 $534,000
Q2 2019 Aug 02, 2019	SELL	$46.61 - $58.45 $31,275 - $39,219	-671 Reduced 6.57%	9,548 $0
Q1 2019 May 02, 2019	SELL	$38.66 - $51.82 $19,484 - $26,117	-504 Reduced 4.7%	10,219 $0
Q4 2018 Feb 06, 2019	SELL	$36.72 - $67.73 $1,799 - $3,318	-49 Reduced 0.45%	10,723 $444,000
Q3 2018 Nov 01, 2018	BUY	$66.65 - $83.86 $128,634 - $161,849	1,930 Added 21.83%	10,772 $627,000
Q2 2018 Aug 01, 2018	BUY	$51.25 - $76.62 $6,662 - $9,960	130 Added 1.49%	8,842 $725,000
Q1 2018 May 01, 2018	BUY	$52.16 - $66.86 $5,789 - $7,421	111 Added 1.29%	8,712 $481,000
Q4 2017 Feb 02, 2018	SELL	$49.6 - $60.87 $54,262 - $66,591	-1,094 Reduced 11.28%	8,601 $514,000
Q3 2017 Nov 06, 2017	BUY	$46.62 - $60.36 $451,980 - $585,190	9,695	9,695 $504,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account